The iCAN flagship is a new innovative cancer research platform formed by the University of Helsinki, Helsinki Universty Hospital and a number of new partners. iCAN integrates precision cancer medicine and digital health/lifestyle data, thereby enabling development of personalized cancer treatments and new health sector innovations.
The Academy of Finland has selected the”iCAN Digital Precision Cancer Medicine” competence cluster as one of Finland’s six flagships. The iCAN public-private partnership forms a platform aiming to improve the treatment of cancer patients and to support innovations coming from high quality research.
Read more here.